← Leaderboards
Margaret E Ackerman
Dartmouth College
$10,872,016
Attributed
$12,838,499
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2012–25$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,838,499 · 8
By mechanism
R01$9,185,882 · 5
U19$2,415,358 · 1
R56$792,039 · 1
R21$445,220 · 1
Top collaborators
- David A. Leib3 shared
- Guido Ferrari1 shared
- Ann Jones Hessell1 shared
Most similar at Dartmouth College
Same institution · by research overlap
- David A. Leib$22,334,432
- Evelyn Turnbaugh$49,538
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesInsightIn VitroVaccine DevelopmentInnovationPathogenVaccinesAntigensResponseMediatingDesignTherapeutic AntibodiesAffinityInfectionEvaluationImmunoglobulin GFc ReceptorVaccine DesignVariantIn VivoAntibody TherapyAntibody EngineeringImmunityVaccination
Grant awards (22)
Mechanisms and means to improve HIV bnAb activity in vivo$834,325
R01 · FY2025 · AI · contact PI
Understanding and optimizing antibody-based interventions against neonatal HSV infection$780,611
R01 · FY2025 · AI · contact PI
Molecular characterization and modeling efficient antibody effector function$442,024
R01 · FY2025 · AI · contact PI
Transferred Immunity$393,104
U19 · FY2025 · AI · contact PI
Understanding and optimizing antibody-based interventions against neonatal HSV infection$785,011
R01 · FY2024 · AI · contact PI
Mechanisms and means to improve HIV bnAb activity in vivo$773,741
R01 · FY2024 · AI · contact PI
Transferred Immunity$512,953
U19 · FY2024 · AI · contact PI
IgG and FcR Characterization in Small Animal Models of RespiratoryDisease$194,514
R21 · FY2024 · AI · contact PI
Understanding and optimizing antibody-based interventions against neonatal HSV infection$801,565
R01 · FY2023 · AI · contact PI
Transferred Immunity$426,678
U19 · FY2023 · AI · contact PI
IgG and FcR Characterization in Small Animal Models of RespiratoryDisease$250,706
R21 · FY2023 · AI · contact PI
New analytic approaches and endpoints in human HIV vaccine correlate studies$792,039
R56 · FY2022 · AI · contact PI
Transferred Immunity$538,557
U19 · FY2022 · AI · contact PI
Transferred Immunity$544,066
U19 · FY2021 · AI · contact PI
Directing Antibody Effector Activity via Controlled IgG Subclass Switching$647,344
R01 · FY2020 · AI · contact PI
Directing Antibody Effector Activity via Controlled IgG Subclass Switching$647,344
R01 · FY2019 · AI · contact PI
Directing Antibody Effector Activity via Controlled IgG Subclass Switching$637,014
R01 · FY2018 · AI · contact PI
Directing Antibody Effector Activity via Controlled IgG Subclass Switching$620,814
R01 · FY2017 · AI · contact PI
Applying High-Performance Protein Engineering Tools to HIV Immunogen Design$513,387
R01 · FY2015 · AI · contact PI
Applying High-Performance Protein Engineering Tools to HIV Immunogen Design$752,375
R01 · FY2014 · AI · contact PI
Applying High-Performance Protein Engineering Tools to HIV Immunogen Design$472,067
R01 · FY2013 · AI · contact PI
Applying High-Performance Protein Engineering Tools to HIV Immunogen Design$478,260
R01 · FY2012 · AI · contact PI